Cosmos Pharmaceutical Stock Return On Asset
COSMOS Pharmaceutical fundamentals help investors to digest information that contributes to COSMOS Pharmaceutical's financial success or failures. It also enables traders to predict the movement of COSMOS Pink Sheet. The fundamental analysis module provides a way to measure COSMOS Pharmaceutical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to COSMOS Pharmaceutical pink sheet.
COSMOS |
COSMOS Pharmaceutical Company Return On Asset Analysis
COSMOS Pharmaceutical's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current COSMOS Pharmaceutical Return On Asset | 0.0521 |
Most of COSMOS Pharmaceutical's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, COSMOS Pharmaceutical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
CompetitionBased on the latest financial disclosure, COSMOS Pharmaceutical has a Return On Asset of 0.0521. This is 100.6% lower than that of the Healthcare sector and significantly higher than that of the Pharmaceutical Retailers industry. The return on asset for all United States stocks is 137.21% lower than that of the firm.
COSMOS Return On Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses COSMOS Pharmaceutical's direct or indirect competition against its Return On Asset to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of COSMOS Pharmaceutical could also be used in its relative valuation, which is a method of valuing COSMOS Pharmaceutical by comparing valuation metrics of similar companies.COSMOS Pharmaceutical is currently under evaluation in return on asset category among its peers.
COSMOS Fundamentals
| Return On Equity | 0.12 | |||
| Return On Asset | 0.0521 | |||
| Profit Margin | 0.03 % | |||
| Operating Margin | 0.04 % | |||
| Current Valuation | 3.89 B | |||
| Shares Outstanding | 39.6 M | |||
| Shares Owned By Insiders | 51.47 % | |||
| Shares Owned By Institutions | 20.75 % | |||
| Price To Book | 2.72 X | |||
| Price To Sales | 0.01 X | |||
| Revenue | 755.41 B | |||
| Gross Profit | 151.45 B | |||
| EBITDA | 48.21 B | |||
| Net Income | 23.16 B | |||
| Total Debt | 3 B | |||
| Book Value Per Share | 5,056 X | |||
| Cash Flow From Operations | 32.19 B | |||
| Earnings Per Share | 4.54 X | |||
| Number Of Employees | 5.1 K | |||
| Beta | 0.26 | |||
| Market Capitalization | 3.89 B | |||
| Total Asset | 363.05 B | |||
| Z Score | 2.6 | |||
| Annual Yield | 0.01 % | |||
| Net Asset | 363.05 B | |||
| Last Dividend Paid | 40.0 |
Currently Active Assets on Macroaxis
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Other Consideration for investing in COSMOS Pink Sheet
If you are still planning to invest in COSMOS Pharmaceutical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the COSMOS Pharmaceutical's history and understand the potential risks before investing.
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum |